Clinical Trials Logo

Clinical Trial Summary

The investigators hypothesize gold is inert and thereby there is no pure-gold allergy. The primary aim of this study is to measure the prevalence of allergy to metallic pure gold microparticles and allergy to GSTS.


Clinical Trial Description

TRUE test panel which includes gold sodium thiosulphate (GSTS), 1 % w/v in petrolatum, and gold microparticles, 20-micron diameter, 1 % w/v in petrolatum, will be added added to the baseline series. It will be applied to the upper back of healthy adults in aluminum Finn Chamber for 48 hours. Clinical evaluation will be performed 24 hours after removal the test according to standard procedures for evaluation of epi-cutaneous challenging (Johansen 2015). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05284253
Study type Interventional
Source Northern Orthopaedic Division, Denmark
Contact Sten Rasmussen, PhD
Phone 25520462
Email sten@dcm.aau.dk
Status Not yet recruiting
Phase N/A
Start date June 1, 2024
Completion date October 30, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04058743 - Nickel Sensitivity N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Not yet recruiting NCT06065137 - Standardised Drug Provocation Testing in Perioperative Hypersensitivity Phase 4
Active, not recruiting NCT05605795 - Investigation of Cross-allergies Between Cefazolin and Amoxicillin With Skin Tests and Provocation Test
Completed NCT04510376 - Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method N/A
Completed NCT05185479 - Analysis of Adverse Events in Anesthesia Using Artificial Intelligence
Recruiting NCT05185362 - Epidemiology of Pecan Nut Allergy
Completed NCT03489694 - Repeatability and Reproducibility of Skin Test Endpoint Titration
Completed NCT03525496 - Interest of Challenge Tests for Diagnosis of Immediate Hypersensitivity Against Iodinated Contrast Agents
Completed NCT03942692 - What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction
Enrolling by invitation NCT05670756 - Preoperative Survey to Evaluate Patient Allergy
Recruiting NCT05462444 - Development of Personalized Balanced Nutrition Concept Through an IT Platform
Completed NCT03157505 - Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis Phase 3
Completed NCT01436617 - Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab Phase 2
Not yet recruiting NCT05532566 - Quercus Ilex and Quercus Robur Allergen Extracts Standardisation N/A
Not yet recruiting NCT05533385 - Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation. N/A
Recruiting NCT06011603 - Prineo Sensitivity Dressing Study Phase 4
Completed NCT04761822 - COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations Phase 2
Recruiting NCT05367531 - Assessment of Injectable Medication Platforms N/A